China approves first oral GLP-1 weight-loss drug
China on Thursday approved Eli Lilly's orforglipron pills, marketed domestically under the brand name "Muyouda," for long-term weight management in adults, making it the country's first oral GLP-1 medication approved for weight loss, according to the National Medical Products Administration (NMPA) and the company's press release on Thursday.